24 Week Safety and Tolerability of Nevirapine Versus Abacavir in Combination with Zidovudine/Lamivudine as First-Line Antiretroviral Therapy: A Randomised Double-Blind Trial (NORA).

Abstract

Objective: To compare the safety/tolerability of abacavir and nevirapine in HIV-infected adults starting antiretroviral (ARV) therapy in Uganda. Methods: Twenty-four-week randomized double-blind trial conducted with 600 symptomatic ARV-naive adults with CD4

Citation

Tropical Medicine & International Health (2008) 13 (1), pp. 6-16 [doi10.111/j.1365-3156.2007.01973.x]

24 Week Safety and Tolerability of Nevirapine Versus Abacavir in Combination with Zidovudine/Lamivudine as First-Line Antiretroviral Therapy: A Randomised Double-Blind Trial (NORA).

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.